Drugs / SII Yellow Fever Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05447377 | Sep 2022 → Jan 2024 | yellow fever | Serum Institute of India Pvt. Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SII Yellow Fever Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05447377 ↗ |
| Known as | SII YF vaccine | “SII YF vaccine: Live attenuated Yellow Fever Virus (17D-213 Strain) not less than 1000 IU/dose propagated in specific pathogen-free chick embryos.” NCT05447377 ↗ |
| Modality | Vaccine | “SII Yellow Fever vaccine is Live attenuated Yellow Fever Virus (17D-213 Strain)” NCT05447377 ↗ |